Clara Alcon Franch

Clara Alcon Franch is a researcher at the Institute for Bioengineering of Catalonia (IBEC) affiliated with the Nanobioengineering Group. Her work focuses on molecular oncology and the development of targeted therapeutic strategies for cancer treatment.

Clara's research explores mechanisms of apoptosis and drug resistance, particularly through BH3 mimetics and CDK9 inhibitors. Her recent studies address clinical efficacy in hematologic malignancies and solid tumors like rhabdomyosarcoma and non-small cell lung cancer.

Her publications highlight trends in targeted therapeutics, apoptosis modulation, and drug combination strategies to overcome resistance. Collaborative efforts span biomedical signal processing, biomaterials, and precision medicine.

Clara contributes to IBEC's Nanobioengineering Group, a multidisciplinary team advancing bioengineered solutions for medical challenges.